Stanford researchers have developed a system for precise genetic modification of human embryonic stem cells (ECSs) and induced pluripotent stem cells (iPSCs).
Researchers in Prof. Vijay Pande's laboratory developed a novel computational technique (“SCISSORS”) that affords several orders of magnitude acceleration in chemical library screening.
Stanford Researchers have patented an improved technique for capturing and processing dynamic and high speed scenes using a collection of precisely timed video cameras. This system uses multiple synchronized image sensors with precise time delays to capture high-speed video.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx1a monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx3a monoclonal antibodies to study transcriptional regulation and embryonic development.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx3b monoclonal antibodies to study transcriptional regulation and embryonic development.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pknox monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Set1p monoclonal antibodies to study chromatin regulation and histone methylation.
A team of researchers from the Stanford Artificial Intelligence Laboratory have patented a portfolio of innovations that harness depth sensing technology to analyze human motion for touch-free control of devices and motion capture.
Soluble CD81 molecules were constructed for the purpose of identifying a postulated ligand to CD81. Recently CD81 has been claimed by others to be a candidate for a receptor for the human hepatitis C virus (HCV).
5A6 is monoclonal antibody (mAbs) which recognizes human CD81. It was identified by its ability to induce a reversible antiproliferative effect on a human lymphoma B cell line. This mAbs is capable of inducing signal signal transduction and cell adhesion.
A team of researchers from the Stanford Artificial Intelligence Laboratory have developed a portfolio of patented innovations that harness depth sensing technology to analyze human motion for touch-free control of devices and motion capture.
This is a Nogo conditional, targeted KO mouse, conditional KO of Nogo that may be used for research puposes. For example, experimented used the mice in the process of investiating myelin inhibitors and spinal cords.